Delirium and Alcohol Withdrawal: Comprehensive Guide and How to use AWS score for Medical Professionals

Introduction

Delirium is a common but serious medical condition characterized by acute confusion, fluctuating consciousness, and cognitive impairment. Among the various causes of delirium, alcohol withdrawal stands out due to its potential severity and complexity. This guide will provide an in-depth look at diagnosing and managing delirium, with a particular focus on alcohol-related delirium, also known as Delirium Tremens (DTs), and the use of the Alcohol Withdrawal Syndrome (AWS) score.

Diagnosing Delirium

Delirium is an acute and often fluctuating disturbance in mental function, characterized by a reduced ability to focus, sustain, or shift attention, disorganized thinking and altered levels of consciousness.

Key Features of Delirium:

• Acute Onset and Fluctuating Course: Symptoms develop rapidly, typically within hours to days, and fluctuate over the course of the day.
• Disturbance in Attention: Patients have a reduced ability to focus, sustain, or shift attention, often appearing distracted or unable to follow conversations.
• Disorganized Thinking: Manifested by incoherent speech, rambling, or irrelevant conversation.
• Altered Level of Consciousness: Ranges from hyper-alertness to lethargy or stupor.

Diagnostic Approach:

• History and Physical Examination: Collect a detailed history from the patient and caregivers to understand the timeline of symptom onset and potential triggers. Perform a comprehensive physical examination to identify any signs that might point to underlying causes.
• Cognitive Assessment: Utilize tools such as the Confusion Assessment Method (CAM) to systematically evaluate the presence of delirium. CAM criteria include:
• Acute onset and fluctuating course
• Inattention
• Disorganized thinking
• Altered level of consciousness
• Identify Underlying Causes: Perform a thorough evaluation to identify potential causes of delirium, such as:
• Infections: Urinary tract infections, pneumonia, sepsis
• Metabolic Disturbances: Electrolyte imbalances (e.g., hyponatremia, hypercalcemia), hypoglycemia
• Medication Side Effects or Withdrawal: Especially in elderly patients or those with polypharmacy
• Hypoxia: Due to respiratory or cardiac conditions
• Acute Organ Failure: Renal or hepatic failure
• Substance Intoxication or Withdrawal: Alcohol, benzodiazepines, opioids

Focus on Alcohol-Related Delirium (Delirium Tremens)

Delirium Tremens (DTs) is a severe form of alcohol withdrawal that requires immediate medical attention. It is characterized by sudden and severe mental or nervous system changes.

Timing:

• Onset: Typically occurs 48-72 hours after the last drink.
• Duration:
• With Treatment: Symptoms can persist up to 7 days.
• Without Treatment: Symptoms can extend up to 10 days or more.

Clinical Features:

• Severe Agitation and Confusion: Marked disorientation, agitation, and hyperactivity.
• Hallucinations: Often visual, but can also be auditory or tactile (e.g., feeling of bugs crawling on the skin).
• Autonomic Hyperactivity:
• Tachycardia: Rapid heart rate
• Hypertension: High blood pressure
• Fever
• Diaphoresis: Excessive sweating
• Tremors: Severe shaking, especially in the hands.
• Seizures: Can occur before or during DTs, typically in the early stages of withdrawal.
• Sleep Disturbances: Insomnia or vivid nightmares.

Pathophysiology:

• Neurotransmitter Imbalance: Chronic alcohol use leads to adaptive changes in the brain, particularly involving GABA (inhibitory) and glutamate (excitatory) neurotransmitters. Abrupt cessation of alcohol results in a hyperexcitable state due to decreased GABAergic activity and increased glutamatergic activity.
• Autonomic Dysregulation: Overactivity of the sympathetic nervous system contributes to the severe physical symptoms of DTs.

Alcohol Withdrawal Syndrome (AWS) Score

The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol Scale, Revised) is a tool used to assess the severity of alcohol withdrawal symptoms and to guide treatment decisions.

Scoring Components:

• Nausea and Vomiting: 0-7
• Tremors: 0-7
• Paroxysmal Sweats: 0-7
• Anxiety: 0-7
• Agitation: 0-7
• Tactile Disturbances: 0-7 (e.g., itching, pins and needles, burning, numbness)
• Auditory Disturbances: 0-7 (e.g., sound sensitivity, hallucinations)
• Visual Disturbances: 0-7 (e.g., light sensitivity, hallucinations)
• Headache: 0-7 (e.g., fullness in head, severe throbbing)
• Orientation and Clouding of Sensorium: 0-4 (0 = oriented, 4 = no sense of time/place or unable to concentrate)

Interpretation:

• 0-9: Absent or minimal withdrawal
• 10-19: Mild to moderate withdrawal
• 20+: Severe withdrawal

Management of Alcohol Withdrawal

Management Based on CIWA-Ar Score:

Mild Withdrawal (CIWA-Ar 0-9):

• Monitor the patient and provide supportive care.
• Ensure adequate hydration and nutrition.
• Administer thiamine (100 mg IV/IM daily) to prevent Wernicke’s encephalopathy.
• Provide multivitamins to address any potential nutritional deficiencies.

Moderate Withdrawal (CIWA-Ar 10-19):

• Consider pharmacologic treatment with benzodiazepines to manage symptoms and prevent progression.
• Diazepam: Commonly used due to its long half-life. Start with 10-20 mg orally or IV, and repeat every 1-2 hours as needed.
• Lorazepam: An alternative, especially for patients with liver dysfunction. Typically 1-4 mg orally or IV every 1-4 hours as needed.
• Chlordiazepoxide: Another option, typically 50-100 mg orally every 4-6 hours as needed.
• Continue supportive care and monitoring.

Severe Withdrawal (CIWA-Ar 20+):

• Aggressive pharmacologic treatment with benzodiazepines is required.
• Diazepam: Start with 10-20 mg orally or IV, then 5-10 mg every 1-2 hours until symptoms are controlled.
• Consider using a continuous infusion if repeated bolus doses are ineffective.
• Frequent monitoring: Check vital signs and CIWA-Ar score every 1-2 hours initially.
• ICU admission may be necessary for severe cases to manage complications such as seizures, severe autonomic instability, or delirium tremens.

Supportive Care:

• Hydration: Administer IV fluids to prevent dehydration and maintain electrolyte balance.
• Electrolyte Correction: Regularly monitor and correct any imbalances, such as hypokalemia or hypomagnesemia.
• Thiamine: Administer 100 mg IV/IM daily to prevent or treat Wernicke’s encephalopathy.
• Multivitamins: Provide additional vitamins to address deficiencies.
• Environmental Control: Ensure a calm, quiet, and well-lit environment with minimal stimuli to reduce agitation and confusion.
• Monitoring: Continuously monitor the patient's clinical status, vital signs, and CIWA-Ar score. Adjust treatment as necessary.

Long-Term Management and Prevention

Post-Acute Care:

• Continued Monitoring: After the acute phase, continue to monitor the patient for any lingering withdrawal symptoms or complications.
• Alcohol Cessation Support: Provide counseling, support groups (e.g., Alcoholics Anonymous), and medications (e.g., naltrexone, acamprosate) to support long-term abstinence.
• Addressing Nutritional Deficiencies: Ensure ongoing supplementation of thiamine and other vitamins to prevent further neurological complications.

Preventing Recurrence:

• Education: Educate patients and their families about the risks of alcohol use and the importance of maintaining abstinence.
• Follow-Up Care: Arrange regular follow-up appointments to monitor the patient’s progress and address any issues related to alcohol dependence or withdrawal.

Summary

Diagnosing Delirium:

• Delirium is characterized by acute onset, fluctuating attention, disorganized thinking, and altered consciousness. Identifying and addressing underlying causes is crucial.

Focus on Alcohol-Related Delirium (DTs):

• Recognize symptoms such as severe agitation, hallucinations, autonomic hyperactivity, and potential seizures. DTs typically onset 48-72 hours after the last drink and can last up to 7-10 days without treatment.

AWS Score:

• The CIWA-Ar scale is used to assess the severity of alcohol withdrawal and guide treatment. Scores range from mild (0-9) to severe (20+).

Management:

• Benzodiazepines (e.g., diazepam) are the primary treatment for moderate to severe withdrawal symptoms.
• Provide supportive care including hydration, electrolyte correction, thiamine, and multivitamins.
• Monitor and adjust treatment based on the CIWA-Ar score and the patient's clinical status.

By following these detailed guidelines, medical professionals can effectively manage alcohol withdrawal and delirium tremens, ensuring comprehensive care and addressing both symptoms and underlying causes.